Paclitaxel (BMS-181339)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Paclitaxel (BMS-181339), covering 2009-11-13 to 2013-07-19. Get the full timeline:
Most recent: Clinical Trial Update: Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer [Phase 2]